Literature DB >> 28968905

Yellow Fever Virus, but Not Zika Virus or Dengue Virus, Inhibits T-Cell Receptor-Mediated T-Cell Function by an RNA-Based Mechanism.

James H McLinden1,2, Nirjal Bhattarai1,2, Jack T Stapleton1,2,3, Qing Chang1,2, Thomas M Kaufman1,2, Suzanne L Cassel1,2, Fayyaz S Sutterwala1,2, Hillel Haim1,2, Jon C Houtman1,2,3, Jinhua Xiang1,2.   

Abstract

The Flavivirus genus within the Flaviviridae family is comprised of many important human pathogens including yellow fever virus (YFV), dengue virus (DENV), and Zika virus (ZKV), all of which are global public health concerns. Although the related flaviviruses hepatitis C virus and human pegivirus (formerly named GBV-C) interfere with T-cell receptor (TCR) signaling by novel RNA and protein-based mechanisms, the effect of other flaviviruses on TCR signaling is unknown. Here, we studied the effect of YFV, DENV, and ZKV on TCR signaling. Both YFV and ZKV replicated in human T cells in vitro; however, only YFV inhibited TCR signaling. This effect was mediated at least in part by the YFV envelope (env) protein coding RNA. Deletion mutagenesis studies demonstrated that expression of a short, YFV env RNA motif (vsRNA) was required and sufficient to inhibit TCR signaling. Expression of this vsRNA and YFV infection of T cells reduced the expression of a Src-kinase regulatory phosphatase (PTPRE), while ZKV infection did not. YFV infection in mice resulted in impaired TCR signaling and PTPRE expression, with associated reduction in murine response to experimental ovalbumin vaccination. Together, these data suggest that viruses within the flavivirus genus inhibit TCR signaling in a species-dependent manner.
© The Author 2017. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  PTPRE; T-cell receptor; flavivirus; virus-derived short RNA; yellow fever virus

Mesh:

Substances:

Year:  2017        PMID: 28968905      PMCID: PMC5853456          DOI: 10.1093/infdis/jix462

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  50 in total

1.  Evidence for a cytoplasmic microprocessor of pri-miRNAs.

Authors:  Jillian S Shapiro; Ryan A Langlois; Alissa M Pham; Benjamin R Tenoever
Journal:  RNA       Date:  2012-05-25       Impact factor: 4.942

2.  Adaptor protein GRB2 promotes Src tyrosine kinase activation and podosomal organization by protein-tyrosine phosphatase ϵ in osteoclasts.

Authors:  Einat Levy-Apter; Eynat Finkelshtein; Vidyasiri Vemulapalli; Shawn S-C Li; Mark T Bedford; Ari Elson
Journal:  J Biol Chem       Date:  2014-11-07       Impact factor: 5.157

3.  Isolation and characterization of a Brazilian strain of yellow fever virus from an epizootic outbreak in 2009.

Authors:  Taissa Ricciardi Jorge; Ana Luiza Pamplona Mosimann; Lucia de Noronha; Angela Maron; Claudia Nunes Duarte Dos Santos
Journal:  Acta Trop       Date:  2016-11-03       Impact factor: 3.112

4.  Characterization of a peptide domain within the GB virus C envelope glycoprotein (E2) that inhibits HIV replication.

Authors:  Jinhua Xiang; James H McLinden; Thomas M Kaufman; Emma L Mohr; Nirjal Bhattarai; Qing Chang; Jack T Stapleton
Journal:  Virology       Date:  2012-05-16       Impact factor: 3.616

5.  Concomitant or sequential administration of live attenuated Japanese encephalitis chimeric virus vaccine and yellow fever 17D vaccine: randomized double-blind phase II evaluation of safety and immunogenicity.

Authors:  Peter E Nasveld; Joanne Marjason; Sonya Bennett; John Aaskov; Suzanne Elliott; Karen McCarthy; Niranjan Kanesa-Thasan; Emmanuel Feroldi; Mark Reid
Journal:  Hum Vaccin       Date:  2010-11-01

6.  Increased susceptibility of Huh7 cells to HCV replication does not require mutations in RIG-I.

Authors:  Dino A Feigelstock; Kathleen B Mihalik; Gerardo Kaplan; Stephen M Feinstone
Journal:  Virol J       Date:  2010-02-19       Impact factor: 4.099

7.  GB virus C particles inhibit T cell activation via envelope E2 protein-mediated inhibition of TCR signaling.

Authors:  Nirjal Bhattarai; James H McLinden; Jinhua Xiang; Alan L Landay; Ernest T Chivero; Jack T Stapleton
Journal:  J Immunol       Date:  2013-05-17       Impact factor: 5.422

8.  ICTV Virus Taxonomy Profile: Flaviviridae.

Authors:  Peter Simmonds; Paul Becher; Jens Bukh; Ernest A Gould; Gregor Meyers; Tom Monath; Scott Muerhoff; Alexander Pletnev; Rebecca Rico-Hesse; Donald B Smith; Jack T Stapleton
Journal:  J Gen Virol       Date:  2017-01       Impact factor: 3.891

9.  Six RNA viruses and forty-one hosts: viral small RNAs and modulation of small RNA repertoires in vertebrate and invertebrate systems.

Authors:  Poornima Parameswaran; Ella Sklan; Courtney Wilkins; Trever Burgon; Melanie A Samuel; Rui Lu; K Mark Ansel; Vigo Heissmeyer; Shirit Einav; William Jackson; Tammy Doukas; Suman Paranjape; Charlotta Polacek; Flavia Barreto dos Santos; Roxana Jalili; Farbod Babrzadeh; Baback Gharizadeh; Dirk Grimm; Mark Kay; Satoshi Koike; Peter Sarnow; Mostafa Ronaghi; Shou-Wei Ding; Eva Harris; Marie Chow; Michael S Diamond; Karla Kirkegaard; Jeffrey S Glenn; Andrew Z Fire
Journal:  PLoS Pathog       Date:  2010-02-12       Impact factor: 6.823

10.  Immune Complexes Indirectly Suppress the Generation of Th17 Responses In Vivo.

Authors:  Ceren Ciraci; John R Janczy; Nidhi Jain; Stefanie Haasken; Cyntia Pecli E Silva; Claudia F Benjamim; Jeffrey J Sadler; Alicia K Olivier; Yoichiro Iwakura; Dmitry M Shayakhmetov; Fayyaz S Sutterwala; Suzanne L Cassel
Journal:  PLoS One       Date:  2016-03-15       Impact factor: 3.240

View more
  6 in total

Review 1.  Yellow Fever Virus: Knowledge Gaps Impeding the Fight Against an Old Foe.

Authors:  Florian Douam; Alexander Ploss
Journal:  Trends Microbiol       Date:  2018-06-19       Impact factor: 17.079

Review 2.  What Does the Future Hold for Yellow Fever Virus? (II).

Authors:  Raphaëlle Klitting; Carlo Fischer; Jan F Drexler; Ernest A Gould; David Roiz; Christophe Paupy; Xavier de Lamballerie
Journal:  Genes (Basel)       Date:  2018-08-21       Impact factor: 4.096

3.  Role of human Pegivirus infections in whole Plasmodium falciparum sporozoite vaccination and controlled human malaria infection in African volunteers.

Authors:  Anneth-Mwasi Tumbo; Tobias Schindler; Jean-Pierre Dangy; Nina Orlova-Fink; Jose Raso Bieri; Maximillian Mpina; Florence A Milando; Omar Juma; Ali Hamad; Elizabeth Nyakarungu; Mwajuma Chemba; Ali Mtoro; Kamaka Ramadhan; Ally Olotu; Damas Makweba; Stephen Mgaya; Kenneth Stuart; Matthieu Perreau; Jack T Stapleton; Said Jongo; Stephen L Hoffman; Marcel Tanner; Salim Abdulla; Claudia Daubenberger
Journal:  Virol J       Date:  2021-01-26       Impact factor: 4.099

4.  T-Cell Expression of Angiotensin-Converting Enzyme 2 and Binding of Severe Acute Respiratory Coronavirus 2.

Authors:  Jennifer L Welch; Jinhua Xiang; Qing Chang; Jon C D Houtman; Jack T Stapleton
Journal:  J Infect Dis       Date:  2022-03-02       Impact factor: 5.226

5.  The Usefulness of a Duplex RT-qPCR during the Recent Yellow Fever Brazilian Epidemic: Surveillance of Vaccine Adverse Events, Epizootics and Vectors.

Authors:  Alice L N Queiroz; Rafael S Barros; Sandro P Silva; Daniela S G Rodrigues; Ana C R Cruz; Flávia B Dos Santos; Pedro F C Vasconcelos; Robert B Tesh; Bruno T D Nunes; Daniele B A Medeiros
Journal:  Pathogens       Date:  2021-06-03

6.  Glycerol Monolaurate, an Analogue to a Factor Secreted by Lactobacillus, Is Virucidal against Enveloped Viruses, Including HIV-1.

Authors:  Jennifer L Welch; Jinhua Xiang; Chioma M Okeoma; Patrick M Schlievert; Jack T Stapleton
Journal:  mBio       Date:  2020-05-05       Impact factor: 7.867

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.